• Je něco špatně v tomto záznamu ?

Lithium rescues cultured rat metatarsals from dexamethasone-induced growth failure

O. Soucek, O. Cinek, L. Velentza, V. Semjonov, M. Bezdicka, F. Zaman, L. Sävendahl

. 2024 ; 96 (4) : 952-963. [pub] 20240429

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25004141
E-zdroje Online Plný text

NLK Free Medical Journals od 1967 do Před 1 rokem
ProQuest Central od 2016-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2016-01-01 do Před 1 rokem
Public Health Database (ProQuest) od 2016-01-01 do Před 1 rokem

BACKGROUND: Glucocorticoids are commonly used in children with different chronic diseases. Growth failure represents a so far untreatable undesired side-effect. As lithium chloride (LiCl) is known to induce cell renewal in various tissues, we hypothesized that LiCl may prevent glucocorticoid-induced growth failure. METHODS: We monitored growth of fetal rat metatarsals cultured ex-vivo with dexamethasone and/or LiCl, while molecular mechanisms were explored through RNA sequencing by implementing the differential gene expression and gene set analysis. Quantification of β-catenin in human growth plate cartilage cultured with dexamethasone and/or LiCl was added for verification. RESULTS: After 14 days of culture, the length of dexamethasone-treated fetal rat metatarsals increased by 1.4 ± 0.2 mm compared to 2.4 ± 0.3 mm in control bones (p < 0.001). The combination of LiCl and dexamethasone led to bone length increase of 1.9 ± 0.3 mm (p < 0.001 vs. dexamethasone alone). By adding lithium, genes for cell cycle and Wnt/β-catenin, Hedgehog and Notch signaling, were upregulated compared to dexamethasone alone group. CONCLUSIONS: LiCl has the potential to partially rescue from dexamethasone-induced bone growth impairment in an ex vivo model. Transcriptomics identified cell renewal and proliferation as candidates for the underlying mechanisms. Our observations may open up the development of a new treatment strategy for bone growth disorders. IMPACT: LiCl is capable to prevent glucocorticoid-induced growth failure in rat metatarsals in vitro. The accompanying drug-induced transcriptomic changes suggested cell renewal and proliferation as candidate underlying mechanisms. Wnt/beta-catenin pathway could be one of those novel mechanisms.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25004141
003      
CZ-PrNML
005      
20250206105949.0
007      
ta
008      
250121s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41390-024-03192-6 $2 doi
035    __
$a (PubMed)38684886
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Soucek, Ondrej $u Vera Vavrova Lab/VIAL, Department of Paediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. ondrej.soucek@lfmotol.cuni.cz $u Paediatric Endocrinology Unit, Department of Children's and Women's Health, Karolinska Institutet, Stockholm, Sweden. ondrej.soucek@lfmotol.cuni.cz
245    10
$a Lithium rescues cultured rat metatarsals from dexamethasone-induced growth failure / $c O. Soucek, O. Cinek, L. Velentza, V. Semjonov, M. Bezdicka, F. Zaman, L. Sävendahl
520    9_
$a BACKGROUND: Glucocorticoids are commonly used in children with different chronic diseases. Growth failure represents a so far untreatable undesired side-effect. As lithium chloride (LiCl) is known to induce cell renewal in various tissues, we hypothesized that LiCl may prevent glucocorticoid-induced growth failure. METHODS: We monitored growth of fetal rat metatarsals cultured ex-vivo with dexamethasone and/or LiCl, while molecular mechanisms were explored through RNA sequencing by implementing the differential gene expression and gene set analysis. Quantification of β-catenin in human growth plate cartilage cultured with dexamethasone and/or LiCl was added for verification. RESULTS: After 14 days of culture, the length of dexamethasone-treated fetal rat metatarsals increased by 1.4 ± 0.2 mm compared to 2.4 ± 0.3 mm in control bones (p < 0.001). The combination of LiCl and dexamethasone led to bone length increase of 1.9 ± 0.3 mm (p < 0.001 vs. dexamethasone alone). By adding lithium, genes for cell cycle and Wnt/β-catenin, Hedgehog and Notch signaling, were upregulated compared to dexamethasone alone group. CONCLUSIONS: LiCl has the potential to partially rescue from dexamethasone-induced bone growth impairment in an ex vivo model. Transcriptomics identified cell renewal and proliferation as candidates for the underlying mechanisms. Our observations may open up the development of a new treatment strategy for bone growth disorders. IMPACT: LiCl is capable to prevent glucocorticoid-induced growth failure in rat metatarsals in vitro. The accompanying drug-induced transcriptomic changes suggested cell renewal and proliferation as candidate underlying mechanisms. Wnt/beta-catenin pathway could be one of those novel mechanisms.
650    _2
$a zvířata $7 D000818
650    12
$a dexamethason $x farmakologie $7 D003907
650    12
$a chlorid lithný $x farmakologie $7 D018021
650    _2
$a krysa rodu Rattus $7 D051381
650    12
$a metatarzální kosti $x účinky léků $7 D008682
650    12
$a beta-katenin $x metabolismus $7 D051176
650    _2
$a signální dráha Wnt $x účinky léků $7 D060449
650    _2
$a lidé $7 D006801
650    _2
$a růstová ploténka $x účinky léků $x metabolismus $7 D006132
650    _2
$a glukokortikoidy $x farmakologie $7 D005938
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a vývoj kostí $x účinky léků $7 D001846
650    _2
$a potkani Sprague-Dawley $7 D017207
655    _2
$a časopisecké články $7 D016428
700    1_
$a Cinek, Ondrej $u Department of Paediatrics and Department of Medical Microbiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Velentza, Lilly $u Paediatric Endocrinology Unit, Department of Children's and Women's Health, Karolinska Institutet, Stockholm, Sweden
700    1_
$a Semjonov, Valerij $u Department of Paediatrics and Department of Medical Microbiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Bezdicka, Martin $u Vera Vavrova Lab/VIAL, Department of Paediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Zaman, Farasat $u Paediatric Endocrinology Unit, Department of Children's and Women's Health, Karolinska Institutet, Stockholm, Sweden
700    1_
$a Sävendahl, Lars $u Paediatric Endocrinology Unit, Department of Children's and Women's Health, Karolinska Institutet, Stockholm, Sweden $u Astrid Lindgren Children ́s Hospital, Karolinska University Hospital, Stockholm, Sweden
773    0_
$w MED00003741 $t Pediatric research $x 1530-0447 $g Roč. 96, č. 4 (2024), s. 952-963
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38684886 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206105945 $b ABA008
999    __
$a ok $b bmc $g 2263722 $s 1240148
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 96 $c 4 $d 952-963 $e 20240429 $i 1530-0447 $m Pediatric research $n Pediatr Res $x MED00003741
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...